Literature DB >> 15062602

Pulmonary injury from transfusion-related acute lung injury.

Patricia M Kopko1, Mark A Popovsky.   

Abstract

Transfusion-related acute lung injury (TRALI) can be a life-threatening complication of transfusion. In its severe form, it is clinically indistinguishable from acute respiratory distress syndrome. Symptoms typically begin within 4 hours of transfusion. TRALI has been reported after transfusion of all plasma-containing blood components. TRALI is associated with antibodies to white blood cells and biologically active lipids in trans-fused blood components.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15062602     DOI: 10.1016/S0272-5231(03)00135-7

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  5 in total

1.  Transfusion-related acute lung injury.

Authors:  Ramakant Dixit; Sidharth Sharma; A R Parmez
Journal:  Asian J Transfus Sci       Date:  2010-07

2.  Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo.

Authors:  Christopher C Silliman; Marguerite R Kelher; Samina Y Khan; Monica LaSarre; F Bernadette West; Kevin J Land; Barbara Mish; Linda Ceriano; Samuel Sowemimo-Coker
Journal:  Blood       Date:  2014-04-18       Impact factor: 22.113

3.  Successful extracorporeal membranous oxygenation for a patient with life-threatening transfusion-related acute lung injury.

Authors:  Hiromitsu Kuroda; Yoshiki Masuda; Hitoshi Imaizumi; Yuji Kozuka; Yasufumi Asai; Akiyoshi Namiki
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

4.  MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice.

Authors:  Richard T Strait; Wyenona Hicks; Nathaniel Barasa; Ashley Mahler; Marat Khodoun; Jörg Köhl; Keith Stringer; David Witte; Nico Van Rooijen; Brian M Susskind; Fred D Finkelman
Journal:  J Exp Med       Date:  2011-10-24       Impact factor: 14.307

5.  Point-of-care washing of allogeneic red blood cells for the prevention of transfusion-related respiratory complications (WAR-PRC): a protocol for a multicenter randomised clinical trial in patients undergoing cardiac surgery.

Authors:  Matthew A Warner; Ian J Welsby; Phillip J Norris; Christopher C Silliman; Sarah Armour; Erica D Wittwer; Paula J Santrach; Laurie A Meade; Lavonne M Liedl; Chelsea M Nieuwenkamp; Brian Douthit; Camille M van Buskirk; Phillip J Schulte; Rickey E Carter; Daryl J Kor
Journal:  BMJ Open       Date:  2017-08-18       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.